Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients

被引:15
作者
Axelson, D [1 ]
Bakken, IJ [1 ]
Gribbestad, IS [1 ]
Ehrnholm, B [1 ]
Nilsen, G [1 ]
Aasly, J [1 ]
机构
[1] SINTEF Unltd, MR Ctr, N-7465 Trondheim, Norway
关键词
Parkinson disease; in vivo; proton MR spectroscopy; artificial neural network; multivariate analysis;
D O I
10.1002/jmri.10125
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To apply neural network analyses to in vivo magnetic resonance spectra of controls and Parkinson disease (PD) patients for the purpose of classification. Materials and Methods: Ninety-seven in vivo proton magnetic resonance spectra of the basal ganglia were recorded from 31 patients with (PD) and 14 age-matched healthy volunteers on a 1.5-T imager. The PD patients were grouped as follows: probable PD (N = 15), Possible PD (N = 11). and atypical PD (N = 5). Total acquisition times of approximately five minutes were achieved with a TE (echo time) of 135 msec, a TR (repetition time) of 2000 msec, and 128 scan averages. Neural network (back propagation, Kohonen, probabilistic, and radial basis function) and related (generative topographic mapping) data analyses were performed. Results: Conventional data analysis showed no statistically significant differences in metabolite ratios based on measuring signal intensities. The trained networks could distinguish control from PD with considerable accuracy (true positive fraction 0.971, true negative fraction 0.933). When four classes were defined. approximately 88% of the predictions were correct. The multivariate analysis indicated metabolic changes in the basal ganglia in PD. Conclusion: A variety of neural network and related approaches can be successfully applied to both qualitative visualization and classification of in vivo spectra of PD patients. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 35 条
[1]   Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from H-1 NMR data of human plasma [J].
AlaKorpela, M ;
Hiltunen, Y ;
Bell, JD .
NMR IN BIOMEDICINE, 1995, 8 (06) :235-244
[2]  
[Anonymous], 1989, GENETIC ALGORITHM SE
[3]  
[Anonymous], 1991, Handbook of genetic algorithms
[4]   Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of epilepsy patients [J].
Bakken, IJ ;
Axelson, D ;
Kvistad, KA ;
Brodtkorb, E ;
Müller, B ;
Aasly, J ;
Gribbestad, IS .
EPILEPSY RESEARCH, 1999, 35 (03) :245-252
[5]  
BISHOP C, 2000, NCRG96015 AST U
[6]  
BOWEN BC, 1995, AM J NEURORADIOL, V16, P61
[7]   Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy [J].
Choe, BY ;
Park, JW ;
Lee, KS ;
Son, BC ;
Kim, MC ;
Kim, BS ;
Suh, TS ;
Lee, HK ;
Shinn, KS .
INVESTIGATIVE RADIOLOGY, 1998, 33 (08) :450-455
[8]   Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy [J].
Clarke, CE ;
Lowry, M ;
Horsman, A .
MOVEMENT DISORDERS, 1997, 12 (03) :297-301
[9]   DIFFERENTIATION OF MULTIPLE SYSTEM ATROPHY FROM IDIOPATHIC PARKINSONS-DISEASE USING PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
DAVIE, CA ;
WENNING, GK ;
BARKER, GJ ;
TOFTS, PS ;
KENDALL, BE ;
QUINN, N ;
MCDONALD, WI ;
MARSDEN, CD ;
MILLER, DH .
ANNALS OF NEUROLOGY, 1995, 37 (02) :204-210
[10]  
ElDeredy W, 1997, NMR BIOMED, V10, P99, DOI 10.1002/(SICI)1099-1492(199705)10:3<99::AID-NBM461>3.0.CO